Literature DB >> 18675414

Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer.

Daniel A Dumesic1, Timothy G Lesnick, Jacques P Stassart, G David Ball, Ashley Wong, David H Abbott.   

Abstract

OBJECTIVE: To investigate the relationship between antimüllerian hormone (AMH) and steroidogenesis in follicles of normoandrogenic ovulatory women undergoing follicle-stimulating hormone (FSH) therapy for in vitro fertilization/embryo transfer (IVF-ET).
DESIGN: Prospective cohort.
SETTING: Institutional/private practice. PATIENT(S): 26 normoandrogenic ovulatory women. All women received gonadotropin-releasing hormone (GnRH) analog and ovarian stimulation for IVF-ET. INTERVENTION(S): Follicle fluid was aspirated at oocyte retrieval from the first follicle of each ovary. MAIN OUTCOME MEASURE(S): Follicle fluid was assayed for AMH, estradiol (E(2)), progesterone, androstenedione, testosterone, dihydrotestosterone, insulin, and FSH. RESULT(S): Intrafollicular AMH levels positively and negatively correlated with E(2) and FSH concentrations in follicles, respectively, causing a positive relationship between follicle fluid AMH levels and E(2)/FSH ratios as a measure of follicle sensitivity to FSH. A positive relationship also existed in follicles between AMH levels and E(2)/androgen ratios as a marker of aromatase activity. CONCLUSION(S): The AMH levels in follicles of IVF patients positively correlate with follicle sensitivity to FSH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18675414      PMCID: PMC2703699          DOI: 10.1016/j.fertnstert.2008.04.047

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  35 in total

1.  Müllerian inhibiting substance as oocyte meiosis inhibitor.

Authors:  M Takahashi; S S Koide; P K Donahoe
Journal:  Mol Cell Endocrinol       Date:  1986-10       Impact factor: 4.102

2.  Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity.

Authors:  S Hirobe; W W He; M M Lee; P K Donahoe
Journal:  Endocrinology       Date:  1992-08       Impact factor: 4.736

3.  Differential effects of epidermal growth factor, somatomedin-C/insulin-like growth factor I, and transforming growth factor-beta on porcine granulosa cell deoxyribonucleic acid synthesis and cell proliferation.

Authors:  J V May; J P Frost; D W Schomberg
Journal:  Endocrinology       Date:  1988-07       Impact factor: 4.736

4.  Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients.

Authors:  Jennifer L Phy; Cheryl A Conover; David H Abbott; Michael A Zschunke; David L Walker; Donna R Session; Ian S Tummon; Alan R Thornhill; Timothy G Lesnick; Daniel A Dumesic
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

5.  Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.

Authors:  C A Wilson; N di Clemente; C Ehrenfels; R B Pepinsky; N Josso; B Vigier; R L Cate
Journal:  Mol Endocrinol       Date:  1993-02

6.  Oocyte regulation of anti-Müllerian hormone expression in granulosa cells during ovarian follicle development in mice.

Authors:  Nicholas A Salmon; Alan H Handyside; Ieuan M Joyce
Journal:  Dev Biol       Date:  2004-02-01       Impact factor: 3.582

7.  Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid müllerian-inhibiting substance and androgen content.

Authors:  D B Seifer; D T MacLaughlin; A S Penzias; H R Behrman; L Asmundson; P K Donahoe; R V Haning; S D Flynn
Journal:  J Clin Endocrinol Metab       Date:  1993-03       Impact factor: 5.958

8.  The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells.

Authors:  J H Kim; M M Seibel; D T MacLaughlin; P K Donahoe; B J Ransil; P A Hametz; C J Richards
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

9.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

Authors:  Christien Weenen; Joop S E Laven; Anne R M Von Bergh; Mark Cranfield; Nigel P Groome; Jenny A Visser; Piet Kramer; Bart C J M Fauser; Axel P N Themmen
Journal:  Mol Hum Reprod       Date:  2004-02       Impact factor: 4.025

10.  Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro.

Authors:  S Ueno; T F Manganaro; P K Donahoe
Journal:  Endocrinology       Date:  1988-09       Impact factor: 4.736

View more
  15 in total

1.  Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.

Authors:  Soledad Henríquez; Paulina Kohen; Xia Xu; Claudio Villarroel; Alex Muñoz; Ana Godoy; Jerome F Strauss; Luigi Devoto
Journal:  Hum Reprod       Date:  2020-07-01       Impact factor: 6.918

2.  Effect of Anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling.

Authors:  Ermioni Prapa; Anna Vasilaki; Konstantinos Dafopoulos; Eleni Katsiani; Panagiotis Georgoulias; Christina I Messini; George Anifandis; Ioannis E Messinis
Journal:  J Assist Reprod Genet       Date:  2015-05-24       Impact factor: 3.412

3.  A novel approach to quantifying ovarian cell lipid content and lipid accumulation in vitro by confocal microscopy in lean women undergoing ovarian stimulation for in vitro fertilization (IVF).

Authors:  Prapti Singh; Marli Amin; Erica Keller; Ariel Simerman; Paul Aguilera; Christine Briton-Jones; David L Hill; David H Abbott; Gregorio Chazenbalk; Daniel A Dumesic
Journal:  J Assist Reprod Genet       Date:  2013-03-20       Impact factor: 3.412

Review 4.  Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function.

Authors:  Anne-Laure Barbotin; Maëliss Peigné; Samuel Andrew Malone; Paolo Giacobini
Journal:  Neuroendocrinology       Date:  2019-07-05       Impact factor: 4.914

5.  Intrafollicular cortisol levels inversely correlate with cumulus cell lipid content as a possible energy source during oocyte meiotic resumption in women undergoing ovarian stimulation for in vitro fertilization.

Authors:  Ariel A Simerman; David L Hill; Tristan R Grogan; David Elashoff; Nigel J Clarke; Ellen H Goldstein; Alexa N Manrriquez; Gregorio D Chazenbalk; Daniel A Dumesic
Journal:  Fertil Steril       Date:  2014-10-24       Impact factor: 7.329

6.  Evaluation of ovarian reserve after laparoscopic surgery in patients with polycystic ovary syndrome.

Authors:  Laya Farzadi; Mohammad Nouri; Morteza Ghojazadeh; Mona Mohiti; Esmat Aghadavod
Journal:  Bioimpacts       Date:  2012-06-25

Review 7.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

8.  21-Hydroxylase-derived steroids in follicles of nonobese women undergoing ovarian stimulation for in vitro fertilization (IVF) positively correlate with lipid content of luteinized granulosa cells (LGCs) as a source of cholesterol for steroid synthesis.

Authors:  Marli Amin; Ariel Simerman; Michele Cho; Prapti Singh; Christine Briton-Jones; David Hill; Tristan Grogan; David Elashoff; Nigel J Clarke; Gregorio D Chazenbalk; Daniel A Dumesic
Journal:  J Clin Endocrinol Metab       Date:  2014-01-13       Impact factor: 5.958

9.  Early prenatal androgenization results in diminished ovarian reserve in adult female rhesus monkeys.

Authors:  D A Dumesic; M S Patankar; D K Barnett; T G Lesnick; B A Hutcherson; D H Abbott
Journal:  Hum Reprod       Date:  2009-09-09       Impact factor: 6.918

10.  High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.

Authors:  Yaxin Guo; Shuai Liu; Shiqiao Hu; Fei Li; Lei Jin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.